FDA approval of Regeneron’s myeloma drug delayed due to manufacturing issues
The US regulator has confirmed a delay to the approval of linvoseltamab while a manufacturing issue is resolved with a third-party provider.
Archives for August 22, 2024
Breaking News: Lecanemab approved in UK but unavailable on NHS
Eisai and Biogen’s new Alzheimer’s treatment, lecanemab, received a green light from UK regulators, marking a significant advance in treating early-stage Alzheimer’s disease.
First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1
ImmPACT Bio has received FDA clearance to start clinical trials for its CD19/CD20 bispecific CAR-T cell therapy in multiple sclerosis (MS) patients.
Adcendo and Multitude target cancer resistance to ADCs in $1BN deal
As antibody-drug conjugates (ADCs) continue to heat up in the industry, Adcendo of Denmark has gained the global rights from Multitude Therapeutics to develop the Chinese company’s ADC for the treatment of cancer outside of the Greater China region.
Breaking barriers in science: Thermo Fisher's Melanie Adams-Cioaba on innovation and inclusion
In the rapidly evolving field of drug discovery, Melanie Adams-Cioaba stands at the forefront, leading transformative advancements in cryo-electron microscopy (cryo-EM) at Thermo Fisher Scientific.